Brief: Standard Biotools Provides Update On Sale Of Mass Cytometry Business
30/09/2026 23:33
BRIEF-Standard Biotools Provides Update On Sale Of Mass Cytometry Business Standard BioTools Inc. LAB.O:
STANDARD BIOTOOLS PROVIDES UPDATE ON SALE OF MASS CYTOMETRY BUSINESS
STANDARD BIOTOOLS: TERMINATED ITS PREVIOUSLY ANNOUNCED AGREEMENT TO SELL ITS MASS CYTOMETRY BUSINESS TO MULTIPLEX BIO
STANDARD BIOTOOLS INC.: ENTERED DEFINITIVE AGREEMENT TO SELL ITS MASS CYTOMETRY BUSINESS TO ELEMENT BIOSYSTEMS FOR $5.5 MILLION IN CASH PAYABLE
Source text: ID:nGNX9NZtf1
Further company coverage: LAB.O
Recent news on Standard BioTools
See all newsBrief: Standard Biotools Announces Agreement To Sell Microfluidics Business To Archimed
Brief: Standard Biotools Provides Update On Sale Of Mass Cytometry Business
Standard BioTools Inc. reports results for the quarter ended June 30 - Earnings Summary
Standard BioTools Q2 revenue falls on consumables weakness
Brief: Standard BioTools Q2 EPS USD -0.07